The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $38.46

Today's change-0.41 -1.05%
Updated February 10 3:24 PM EST. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $38.46

Today's change-0.41 -1.05%
Updated February 10 3:24 PM EST. Delayed by at least 15 minutes.

Sanofi SA down (U.S.)$0.41

Sanofi SA is lower today, dropping (U.S.)$0.41 or 1.05% to (U.S.)$38.46. Over the last five days, shares have lost 6.26% and are down 9.82% for the last year to date. This security has underperformed the S&P 500 by 10.15% during the last year.

Key company metrics

  • Open(U.S.) $38.43
  • Previous close(U.S.) $38.87
  • High(U.S.) $38.89
  • Low(U.S.) $38.39
  • Bid / Ask(U.S.) $38.46 / (U.S.) $38.47
  • YTD % change-9.82%
  • Volume1,794,657
  • Average volume (10-day)1,799,544
  • Average volume (1-month)1,889,351
  • Average volume (3-month)1,687,349
  • 52-week range(U.S.) $38.33 to (U.S.) $54.98
  • Beta1.04
  • Trailing P/E17.21×
  • P/E 1 year forward12.62×
  • Forward PEG1.97×
  • Indicated annual dividend(U.S.) $1.61
  • Dividend yield4.18%
  • Trailing EPS(U.S.) $2.23
Updated February 10 3:24 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.54%

Based on its net profit margin of 14.54%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.57%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue9,6809,4618,89018,038
Total other revenue--------
Total revenue9,6809,4618,89018,038
Gross profit6,6826,5236,10412,133
Total cost of revenue2,9982,9382,7865,905
Total operating expense7,7257,4667,48714,569
Selling / general / administrative2,4612,6482,4384,774
Research & development1,3551,2901,1992,497
Depreciation / amortization5986116181,181
Interest expense (income), net operating--------
Unusual expense (income)26729380176
Other operating expenses, total46-506636
Operating income1,9551,9951,4033,469
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,8501,8831,3063,192
Income after tax1,5781,3641,0862,645
Income tax, total272519220547
Net income1,6281,3021,0232,529
Total adjustments to net income--------
Net income before extra. items1,6281,3021,0232,529
Minority interest-23-27-32-58
Equity in affiliates73-35-31-58
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,6281,3021,0232,529
Inc. avail. to common incl. extra. items1,6281,3021,0232,529
Diluted net income1,6281,3021,0232,529
Dilution adjustment--------
Diluted weighted average shares1,3131,3061,3081,345
Diluted EPS excluding extraordinary itemsvalue per share1.241.000.781.88
Dividends per sharevalue per share0.000.000.001.58
Diluted normalized EPSvalue per share1.411.011.021.99